AtaiBeckley (ATAI) Non Operating Income (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Non Operating Income came in at $1.1 million in Q1 2026, up 118.84% year-on-year from $511328.8 in Q1 2025, and up 118.84% quarter-over-quarter from -$5.9 million in Q1 2025.
AtaiBeckley (ATAI) Non Operating Income (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Non Operating Income data on file, last reported at -$32.5 million in Q3 2025.
- For the quarter ending Q3 2025, Non Operating Income fell 742.55% year-over-year to -$32.5 million; the trailing twelve-month figure through Sep 2025 stood at -$49.8 million (down 130.8% YoY), and the FY2024 full-year result was -$45.7 million, down 153.04% from the prior year.
- Non Operating Income advanced to $1.1 million in Q1 2026 per ATAI's latest filing, from -$5.9 million in the prior quarter.
- Across five years, Non Operating Income topped out at $1.1 million in Q1 2026 and bottomed at -$5.9 million in Q1 2025.
- A 5-year average of $443105.3 and a median of -$1.6 million in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 1236.38% in 2023 and plunged 15466.67% in 2024, its largest moves.
- Tracing ATAI's Non Operating Income over 5 years: stood at -$3.4 million in 2021, then jumped by 48.41% to -$1.8 million in 2022, then surged by 967.94% to $15.2 million in 2023, then plunged by 158.52% to -$8.9 million in 2024, then plunged by 264.74% to -$32.5 million in 2025.
- Business Quant data shows ATAI's Non Operating Income at -$32.5 million in Q3 2025, -$2.4 million in Q2 2025, and -$5.9 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -32.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Sep 30, 2025 | -32.53 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | -5.94 Mn |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Sep 30, 2024 | -3.86 Mn |
| Jun 30, 2024 | -31.35 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | 15.24 Mn |
| Sep 30, 2023 | 70.68 Mn |
| Jun 30, 2023 | 204,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | -1.76 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | -3.40 Mn |
| Sep 30, 2021 | 6.89 Mn |
| Jun 30, 2021 | -5.98 Mn |